Group 1 - The company held its 12th meeting of the 5th Board of Directors on July 3, 2025, with all 7 directors present, ensuring compliance with relevant laws and regulations [1] - The Board approved the draft of the 2025 Restricted Stock Incentive Plan to attract and retain talent while aligning the interests of shareholders, the company, and employees [1][2] - The plan aims to establish a long-term incentive mechanism and requires approval from the shareholders' meeting with a two-thirds majority [2][3] Group 2 - The Board also approved the implementation assessment management measures for the 2025 Restricted Stock Incentive Plan, which will be disclosed on the same day [2][3] - The Board proposed to authorize itself to handle various matters related to the implementation of the incentive plan, including determining eligibility and adjusting stock grants [4][5] - A temporary shareholders' meeting is scheduled for July 22, 2025, to further discuss the incentive plan [6]
美农生物: 第五届董事会第十二次会议决议公告